Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
8015 | 1227 | 34.6 | 55% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
3102 | 1835 | MEYERS INTERDISCIPLINARY ORGAN MED CHE//BLEOMYCIN HYDROLASE//BLEOMYCIN AMPLIFICATION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | BLEOMYCIN HYDROLASE | Author keyword | 20 | 63% | 2% | 20 |
2 | BLEOMYCIN BINDING PROTEIN | Author keyword | 12 | 86% | 0% | 6 |
3 | BLEOMYCIN RESISTANCE | Author keyword | 9 | 67% | 1% | 8 |
4 | STREPTOMYCES VERTICILLUS | Author keyword | 6 | 58% | 1% | 7 |
5 | BLEOMYCIN A2 | Author keyword | 5 | 60% | 0% | 6 |
6 | BLM3 | Author keyword | 4 | 75% | 0% | 3 |
7 | BLEOMYCIN COMPLEXES | Author keyword | 3 | 100% | 0% | 3 |
8 | BLM5 | Author keyword | 3 | 100% | 0% | 3 |
9 | DEGLYCOBLEOMYCIN A2 | Author keyword | 3 | 100% | 0% | 3 |
10 | TALLYSOMYCIN | Author keyword | 3 | 100% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BLEOMYCIN HYDROLASE | 20 | 63% | 2% | 20 | Search BLEOMYCIN+HYDROLASE | Search BLEOMYCIN+HYDROLASE |
2 | BLEOMYCIN BINDING PROTEIN | 12 | 86% | 0% | 6 | Search BLEOMYCIN+BINDING+PROTEIN | Search BLEOMYCIN+BINDING+PROTEIN |
3 | BLEOMYCIN RESISTANCE | 9 | 67% | 1% | 8 | Search BLEOMYCIN+RESISTANCE | Search BLEOMYCIN+RESISTANCE |
4 | STREPTOMYCES VERTICILLUS | 6 | 58% | 1% | 7 | Search STREPTOMYCES+VERTICILLUS | Search STREPTOMYCES+VERTICILLUS |
5 | BLEOMYCIN A2 | 5 | 60% | 0% | 6 | Search BLEOMYCIN+A2 | Search BLEOMYCIN+A2 |
6 | BLM3 | 4 | 75% | 0% | 3 | Search BLM3 | Search BLM3 |
7 | BLEOMYCIN COMPLEXES | 3 | 100% | 0% | 3 | Search BLEOMYCIN+COMPLEXES | Search BLEOMYCIN+COMPLEXES |
8 | BLM5 | 3 | 100% | 0% | 3 | Search BLM5 | Search BLM5 |
9 | DEGLYCOBLEOMYCIN A2 | 3 | 100% | 0% | 3 | Search DEGLYCOBLEOMYCIN+A2 | Search DEGLYCOBLEOMYCIN+A2 |
10 | TALLYSOMYCIN | 3 | 100% | 0% | 3 | Search TALLYSOMYCIN | Search TALLYSOMYCIN |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FE BLEOMYCIN | 125 | 88% | 5% | 59 |
2 | A2 GREEN | 116 | 97% | 3% | 33 |
3 | ACTIVATED BLEOMYCIN | 101 | 63% | 8% | 102 |
4 | SELECTIVE DNA CLEAVAGE | 64 | 100% | 2% | 21 |
5 | CENTER DOT BLEOMYCIN | 50 | 88% | 2% | 23 |
6 | MAN DESIGNED BLEOMYCINS | 49 | 94% | 1% | 17 |
7 | IRON BLEOMYCIN | 44 | 65% | 3% | 42 |
8 | BITHIAZOLE MOIETY | 24 | 91% | 1% | 10 |
9 | CARBON MONOXIDE COMPLEX | 21 | 41% | 3% | 39 |
10 | FERROUS BLEOMYCIN | 18 | 89% | 1% | 8 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Cleavage of nucleic acids by bleomycin | 1998 | 358 | 134 | 81% |
Nucleic acid recognition by metal complexes of bleomycin | 1999 | 167 | 164 | 92% |
Bleomycin: New perspectives on the mechanism of action | 2000 | 242 | 95 | 78% |
Direct hydrogen-atom abstraction by activated bleomycin: An experimental and computational study | 2006 | 69 | 89 | 64% |
Bleomycins: A structural model for specificity, binding, and double strand cleavage | 1996 | 173 | 87 | 86% |
MECHANISMS OF BLEOMYCIN-INDUCED DNA-DEGRADATION | 1987 | 890 | 110 | 56% |
Bleomycins: Towards better therapeutics | 2005 | 241 | 92 | 51% |
Bleomycin: Synthetic and mechanistic studies | 1999 | 72 | 164 | 90% |
Bleomycins: new methods will allow reinvestigation of old issues | 2004 | 36 | 38 | 74% |
Nature of activated bleomycin | 2000 | 58 | 66 | 88% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CNRS UMR2027 | 1 | 50% | 0.1% | 1 |
2 | NUCLEIC ACID CHEM | 1 | 50% | 0.1% | 1 |
3 | RECH PHYS CNRS 71 | 1 | 29% | 0.2% | 2 |
4 | NRCAM | 0 | 20% | 0.2% | 2 |
5 | DR ALM POST BAS MED SCI | 0 | 33% | 0.1% | 1 |
6 | ESTUDIO CO ORAT LATINOAMER MALFORMAC CONGENITAS | 0 | 33% | 0.1% | 1 |
7 | MODELAJE MOL | 0 | 33% | 0.1% | 1 |
8 | RADIOPHARMACEUT DEV RRDL | 0 | 33% | 0.1% | 1 |
9 | UER MED BIOL HUMAINE | 0 | 33% | 0.1% | 1 |
10 | IST NAZL STUDIO CURA TUMORI FDN G PASCALE | 0 | 25% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000073765 | BLEOMYCIN//PULMONARY FIBROSIS//LUNG FIBROSIS |
2 | 0.0000071504 | MOL LIFE SCI BK 21//PYRIDINE 2 6 DICARBOXAMIDE//PYRIDINE CARBOXAMIDE |
3 | 0.0000059165 | DIPARTIMENTO AGROCHIM AGROBIOL//DR ISOTHERM//LAGERGREN RATE EQUATION |
4 | 0.0000057198 | HOMOCYSTEINE THIOLACTONE//PROTEIN N HOMOCYSTEINYLATION//DIETARY HYPERHOMOCYSTEINEMIA |
5 | 0.0000056516 | HYPERTHERMIC SENSITIVITY//CELLULAR CHOLESTEROL CONTENT//HIV 1 THERAPY |
6 | 0.0000052817 | ENEDIYNES//ENEDIYNE//BERGMAN CYCLIZATION |
7 | 0.0000052525 | PHARMACEUT SCI BUNKYO MACHI 114//SELECTED ANTIBODY ENZYME IMMUNOASSAY//CELL BIOL IBHV |
8 | 0.0000046617 | MET BIOCATALYSIS//BIOMIMET SYST//NONHEME IRON ENZYMES |
9 | 0.0000046002 | SPIROIMINODIHYDANTOIN//LES ACIDES NUCL//GUANIDINOHYDANTOIN |
10 | 0.0000041040 | BUCCAL DRUG ABSORPTION//HUMAN ENDOMETRIAL ADENOCARCINOMA//BIOL CHEM ERNAHRUNGSWISSEN AFT |